Skip to content
MedsAcross

Medicine

Tramadol 200 mg extended-release tablet

Tramadol · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIVGeneric name

Tramadol 200 mg extended-release tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Key facts

Active ingredient (INN)
Tramadol
Brand
Sold under the generic name
Strength
200 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
30 tablets, 100 tablets, 1000 tablets and 43 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaMacleods PharmaceuticalsIndiaLupinIndiaBryant Ranch PrepackAsclemedProficient RxAdvanced Rx Pharmacy of TennesseeDirect_Rx11 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIV
ATC code
N02AX02 Tramadol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 September 2011
Identifiers
RxCUI 833709, 833711, 833713 +4DailyMed set ID 3e0ccb95-3e8e-477c-b4d2-6060ee05f930, b2f3f007-6dda-4532-9f7f-d93f6e65254c, 0bff5535-0239-409e-8a2a-99d5ba38cca3 +15NDC 68180-384, 63629-8319, 71205-468 +15Application ANDA200503, ANDA201384, ANDA091607 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 11 labelers. The register lists 46 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
30 tablet, extended release in 1 bottle68180-698-06LupinIndia19 August 2014
100 tablet, extended release in 1 bottle47335-533-08Sun Pharmaceutical IndustriesIndia30 December 2011
1000 tablet, extended release in 1 bottle47335-533-18Sun Pharmaceutical IndustriesIndia30 December 2011
30 tablet, extended release in 1 bottle47335-533-83Sun Pharmaceutical IndustriesIndia30 December 2011
100 tablet, extended release in 1 bottle47335-533-88Sun Pharmaceutical IndustriesIndia30 December 2011
100 tablet, extended release in 1 bottle47335-860-08Sun Pharmaceutical IndustriesIndia12 December 2011
1000 tablet, extended release in 1 bottle47335-860-18Sun Pharmaceutical IndustriesIndia12 December 2011
30 tablet, extended release in 1 bottle47335-860-83Sun Pharmaceutical IndustriesIndia12 December 2011
100 tablet, extended release in 1 bottle47335-860-88Sun Pharmaceutical IndustriesIndia12 December 2011
30 tablet, film coated, extended release in 1 bottle33342-270-07Macleods PharmaceuticalsIndia31 January 2025
90 tablet, film coated, extended release in 1 bottle33342-270-10Macleods PharmaceuticalsIndia31 January 2025
100 tablet, film coated, extended release in 1 bottle33342-270-11Macleods PharmaceuticalsIndia31 January 2025
30 tablet, extended release in 1 bottle80425-0127-1Advanced Rx Pharmacy of Tennessee30 December 2011
60 tablet, extended release in 1 bottle80425-0127-2Advanced Rx Pharmacy of Tennessee30 December 2011
30 tablet, extended release in 1 bottle80425-0136-1Advanced Rx Pharmacy of Tennessee22 May 2023
60 tablet, extended release in 1 bottle80425-0136-2Advanced Rx Pharmacy of Tennessee19 August 2014
30 tablet, extended release in 1 bottle76420-245-30Asclemed25 July 2022
60 tablet, extended release in 1 bottle76420-245-60Asclemed25 July 2022
90 tablet, extended release in 1 bottle76420-245-90Asclemed25 July 2022
30 tablet, extended release in 1 bottle76420-537-30Asclemed16 February 2023
60 tablet, extended release in 1 bottle76420-537-60Asclemed16 February 2023
90 tablet, extended release in 1 bottle76420-537-90Asclemed16 February 2023
30 tablet, extended release in 1 bottle63629-8319-1Bryant Ranch Prepack4 June 2020
60 tablet, extended release in 1 bottle63629-8319-2Bryant Ranch Prepack14 May 2020
90 tablet, extended release in 1 bottle63629-8319-3Bryant Ranch Prepack3 December 2020
120 tablet, extended release in 1 bottle63629-8319-4Bryant Ranch Prepack3 April 2024
30 tablet, extended release in 1 bottle71335-1676-1Bryant Ranch Prepack10 July 2020
60 tablet, extended release in 1 bottle71335-1676-2Bryant Ranch Prepack8 July 2020
90 tablet, extended release in 1 bottle71335-1676-3Bryant Ranch Prepack13 August 2020
120 tablet, extended release in 1 bottle71335-1676-4Bryant Ranch Prepack4 April 2024
30 tablet, extended release in 1 bottle61919-893-30Direct RX26 June 2015
60 tablet, extended release in 1 bottle61919-893-60Direct RX1 January 2014
30 tablet, extended release in 1 bottle72189-154-30Direct RX10 November 2020
60 tablet, extended release in 1 bottle72189-154-60Direct RX10 November 2020
30 tablet, extended release in 1 bottle71205-468-30Proficient Rx13 August 2020
60 tablet, extended release in 1 bottle71205-468-60Proficient Rx13 August 2020
90 tablet, extended release in 1 bottle71205-468-90Proficient Rx13 August 2020
30 tablet, extended release in 1 bottle71205-708-30Proficient Rx31 October 2022
60 tablet, extended release in 1 bottle71205-708-60Proficient Rx31 October 2022
90 tablet, extended release in 1 bottle71205-708-90Proficient Rx31 October 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 3 March 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Tramadol

Clinical summary

Tramadol is an opioid agonist indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids, among other approved uses. MedsAcross supplies Tramadol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Tramadol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tramadol 200 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.